Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.

Podobne zapisy

• JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
  od: Vyas, P, i wsp.
  Wydane: (2008)
• Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
  od: Alford, K, i wsp.
  Wydane: (2011)
• Modification of the histone landscape with JAK inhibition in myeloproliferative neoplasms
  od: Greenfield, G, i wsp.
  Wydane: (2020)
• Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
  od: Tunstall, O, i wsp.
  Wydane: (2018)
• Potential role of JAK-STAT signaling pathway in the neurogenic-to-gliogenic shift in down syndrome brain
  od: Lee, Han Chung, i wsp.
  Wydane: (2016)